In Antibiotics (Basel, Switzerland)
Antibiotic resistance (AR) is a naturally occurring phenomenon with the capacity to render useless all known antibiotics in the fight against bacterial infections. Although bacterial resistance appeared before any human life form, this process has accelerated in the past years. Important causes of AR in modern times could be the over-prescription of antibiotics, the presence of faulty infection-prevention strategies, pollution in overcrowded areas, or the use of antibiotics in agriculture and farming, together with a decreased interest from the pharmaceutical industry in researching and testing new antibiotics. The last cause is primarily due to the high costs of developing antibiotics. The aim of the present review is to highlight the techniques that are being developed for the identification of new antibiotics to assist this lengthy process, using artificial intelligence (AI). AI can shorten the preclinical phase by rapidly generating many substances based on algorithms created by machine learning (ML) through techniques such as neural networks (NN) or deep learning (DL). Recently, a text mining system that incorporates DL algorithms was used to help and speed up the data curation process. Moreover, new and old methods are being used to identify new antibiotics, such as the combination of quantitative structure-activity relationship (QSAR) methods with ML or Raman spectroscopy and MALDI-TOF MS combined with NN, offering faster and easier interpretation of results. Thus, AI techniques are important additional tools for researchers and clinicians in the race for new methods of overcoming bacterial resistance.
Popa Stefan Lucian, Pop Cristina, Dita Miruna Oana, Brata Vlad Dumitru, Bolchis Roxana, Czako Zoltan, Saadani Mohamed Mehdi, Ismaiel Abdulrahman, Dumitrascu Dinu Iuliu, Grad Simona, David Liliana, Cismaru Gabriel, Padureanu Alexandru Marius
2022-Nov-21
adaptive resistance, antibiotic development, antibiotic resistance, artificial intelligence (AI), automated antibiotic discovery, computer-aided drug discovery, deep learning, future of medicine, machine learning, neural networks
